Breaking News Instant updates and real-time market news.

WTW

Weight Watchers

$79.47

3.11 (4.07%)

, SYX

Systemax

$36.55

-0.57 (-1.54%)

10:20
08/29/18
08/29
10:20
08/29/18
10:20

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Weight Watchers (WTW) initiated with an Outperform at Oppenheimer. 2. Systemax (SYX) initiated with a Market Perform at William Blair. 3. Broadridge (BR) initiated with a Buy at SunTrust. 4. Mercury General (MCY) initiated with an Outperform at Keefe Bruyette. 5. Immune Design (IMDZ) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

WTW

Weight Watchers

$79.47

3.11 (4.07%)

SYX

Systemax

$36.55

-0.57 (-1.54%)

BR

Broadridge

$134.39

1.33 (1.00%)

MCY

Mercury General

$53.21

0.91 (1.74%)

IMDZ

Immune Design

$3.55

0.125 (3.65%)

  • 05

    Sep

  • 27

    Sep

WTW Weight Watchers
$79.47

3.11 (4.07%)

08/28/18
OPCO
08/28/18
INITIATION
Target $98
OPCO
Outperform
Weight Watchers initiated with an Outperform at Oppenheimer
Oppenheimer analyst Brian Nagel started Weight Watchers with an Outperform rating and $98 price target. A "significant transformation" is taking place at Weight Watchers under new CEO Mindy Grossman, Nagel tells investors in a research note. The analyst sees potential for a "sustained, stronger and higher margin growth trajectory" and believes the recent pullback in the shares is related to technicals, not fundamentals. He thinks the stock offers 30% upside.
08/27/18
DADA
08/27/18
NO CHANGE
Target $143
DADA
Buy
Weight Watchers valuation 'very attractive', says DA Davidson
DA Davidson analyst Linda Bolton Weiser kept her Buy rating and $143 price target on Weight Watchers after her meeting with its CEO Mindy Grossman at the company's WW GOOD Festival in New York, which she states was the biggest of its 6 festivals. Weiser cites Grossman touting the event's "healthy habits" booths as potential areas of expansion and believes that "skin, sleep, and hydration booths seemed like particularly relevant products" areas. With Weight Watchers stock down 27% from its June highs, the analyst further notes that its valuation is "very attractive", trading at 15.7-times her expected forward earnings, while the company's 2018 sales growth trend of 19% is above its 15%-16% annualized 3-year target.
08/07/18
JPMS
08/07/18
NO CHANGE
Target $120
JPMS
Overweight
Weight Watchers price target raised to $120 from $105 at JPMorgan
JPMorgan analyst Christina Brathwaite raised his price target for Weight Watchers International to $120 following the company's Q2 results. Guidance was raised on better than expected constant currency revenue growth, which fully offset a currency headwind in the second half of the year, as well as better than expected gross margins, Brathwaite tells investors in a research note. The analyst sees "significant potential" for earnings leverage in 2018 and keeps an Overweight rating on Weight Watchers.
08/07/18
RILY
08/07/18
NO CHANGE
Target $113
RILY
Buy
Weight Watchers price target raised to $113 from $103 at B. Riley FBR
B. Riley FBR analyst Kara Anderson raised her price target for Weight Watchers to $113 citing increased margin expectations following the company's Q2 results. The analyst keeps a Buy rating on the shares.
SYX Systemax
$36.55

-0.57 (-1.54%)

08/29/18
08/29/18
INITIATION

Market Perform
William Blair starts Systemax at Market Perform on 'full valuation'
As previously reported, William Blair analyst Ryan Merkel earlier today initiated coverage of Systemax (SYX) with a Market Perform rating. Systemax is well positioned to achieve its near-term target of 10% EBITDA margins and sales of $1B, Merkel tells investors in a research note. The analyst, however, views the company's current valuation as "full" and thinks the industrial cycle is potentially nearing its peak.
08/29/18
WBLR
08/29/18
INITIATION
WBLR
Market Perform
Systemax initiated with a Market Perform at William Blair
William Blair analyst Ryan Merkel started Systemax with a Market Perform rating.
08/22/18
08/22/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. SIDOTI UPGRADES SYSTEMAX TO BUY: Sidoti analyst Anthony Lebiedzinski upgraded Systemax (SYX) to Buy from Neutral. The analyst said the recent selloff in shares is overdone and maintained a $45 price target. Systemax shares are up 10.2% in morning trading. PIPER CUTS STARBUCKS TO NEUTRAL: Piper Jaffray analyst Nicole Miller Regan downgraded Starbucks (SBUX) last night to Neutral from Overweight and lowered her price target for the shares to $53 from $60. The motivation for the downgrade was another month of U.S. checks that suggested a lack of comp performance, Miller Regan said. The analyst believes shares of Starbucks will be "range bound at best" until U.S. trends improve. She sees issues around "inconsistent results, credibility of guidance, and management transitions." Miller Regan thinks the stock has "modest downside risk." MKM BOOSTS NETFLIX TARGET TO $395: MKM Partners analyst Rob Sanderson raised his price target for Netflix (NFLX) to $395 from $390 and kept a Buy rating on the shares after updating his estimates. The analyst said his "previous caution" on the shares is "now reversed" following the recent stock price correction. His subscriber ramp expectations are "somewhat lower" in the near-to-medium term but remain unchanged in the long-term. Netflix will approach full penetration of the U.S. over time, growing to 90M subscribers by 2025, Sanderson said. He continues to see over $40 per share in earnings power at 90M U.S. and 300M international subscribers, which he projected in the 2025 timeframe. Expectations for Netflix became "somewhat elevated, but have been appropriately moderated," Sanderson contended. He called the stock a "must-own for growth managers." BAIRD SAYS STAR WARS LICENSE ADDS VISIBILITY FOR ZYNGA: Baird analyst Colin Sebastian believes the Star Wars license announced adds some visibility to Zynga's (ZNGA) out-year growth targets. The new Disney (DIS) license is a positive development for Zynga for the longer-term given the popularity of the Star Wars franchise, Sebastian said. That said, he does not expect a material contribution from new titles until 2020. As such, Sebastian kept a Neutral rating on Zynga shares. Znga shares are up 7.6% in late morning trading. PIPER SAYS FACEBOOK USERS 'UNFAZED' BY ISSUES: Piper Jaffray analyst Michael Olson said his firm's survey of 1,300 Facebook (FB) and Instagram users leaves him confident that "most are unfazed by the negative news flow." The analyst kept an Overweight rating on Facebook shares with a $200 price target.
08/22/18
08/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1.Systemax (SYX) upgraded to Buy from Neutral at Sidoti with analyst Anthony Lebiedzinski saying the recent selloff in shares is overdone. 2. Itron (ITRI) upgraded to Buy from Hold at Argus with analyst John Eade saying while the stock price has trended in a bearish pattern until recently and latest earnings have underperformed, its bookings appear to be in "solid shape." 3. Landstar System (LSTR) upgraded to Outperform from Market Perform at Wells Fargo with analyst Casey Deak saying he has become more positive on the brokerage space moving into 2019. 4. YRC Worldwide (YRCW) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra saying he believes continued pricing and yield improvement, renewal of YRC's aging fleet and opportunities to improve labor flexibility and driver productivity will drive better equity value. 5. MercadoLibre (MELI) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying he believes Q2 was a "transitional" quarter and that management reacted quickly to the Correios price increase by finding the right balance between growth and profitability to position the company well for the long term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BR Broadridge
$134.39

1.33 (1.00%)

07/17/18
WOLF
07/17/18
INITIATION
Target $128
WOLF
Peer Perform
Broadridge initiated with a Peer Perform at Wolfe Research
Wolfe Research analyst Darrin Peller started Broadridge with a Peer Perform rating and $128 price target.Target $128.
11/09/17
DADA
11/09/17
NO CHANGE
Target $86
DADA
Neutral
Broadridge price target raised to $86 from $80 at DA Davidson
DA Davidson analyst Peter Heckmann raised his price target on Broadridge to $86 and kept his Neutral rating following Q1 results. Heckmann estimates the company's organic revenue growth around 2%-3%, adding that while as much as 80% of its sales are "contractually recurring and fairly predictable", earnings variations are possible due to high-margin equity trade processing and event-driven proxy revenue streams.
08/29/18
RHCO
08/29/18
INITIATION
Target $150
RHCO
Buy
Broadridge initiated with a Buy at SunTrust
SunTrust analyst Oscar Turner initiated Broadridge with a Buy rating and a price target of $150, saying the company will continue to gain "meaningful customer wallet share" and generate long-term mid-single-digit organic revenue growth. Turner adds that the operating leverage of Broadridge suggests "at least" high-single-digit EPS expansion that should be consistent through its current cycle. The analyst believes that the company's "enduring" competitive advantages are derived from " regulatory-driven demand, scale, and few substitute solutions".
MCY Mercury General
$53.21

0.91 (1.74%)

08/28/18
KBWI
08/28/18
INITIATION
Target $64
KBWI
Outperform
Mercury General initiated with an Outperform at Keefe Bruyette
Keefe Bruyette analyst Christopher Campbell initiated Mercury General with an Outperform rating and $64 price target, stating that he expects upside driven by auto rate increases and lower adverse reserve charges.
IMDZ Immune Design
$3.55

0.125 (3.65%)

10/17/17
RBCM
10/17/17
NO CHANGE
Target $23
RBCM
Outperform
Immune Design weakness a buying opportunity, says RBC Capital
RBC Capital said Outperform rated Immune Design's positive FDA feedback on Phase III Trial for CMB305 is a de-risking event. The firm's analyst said the timeline could be pushed back slightly, but improves ultimate POS, while maintaining optionality. RBC recommends buying shares on weakness and raised the price target on shares to $23 from $20 .
10/17/17
WELS
10/17/17
DOWNGRADE
WELS
Market Perform
Immune Design downgraded to Market Perform from Outperform at Wells Fargo
08/29/18
HCWC
08/29/18
INITIATION
Target $11
HCWC
Buy
Immune Design initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis started Immune Design with a Buy rating and $11 price target. The company is engaging the immune system through different avenues and targeting significant unmet medical needs, Pantginis tells investors in a research note. The analyst projects mmune Design could be a leader in the resurgence of cancer vaccines.
09/14/17
RBCM
09/14/17
INITIATION
Target $20
RBCM
Outperform
Immune Design initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams started Immune Design with an Outperform rating and $20 price target.

TODAY'S FREE FLY STORIES

ASPS

Altisource

$34.41

0.31 (0.91%)

02:55
09/25/18
09/25
02:55
09/25/18
02:55
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

02:10
09/25/18
09/25
02:10
09/25/18
02:10
General news
FX Action: USD-JPY posted a two-month high »

FX Action: USD-JPY posted…

01:35
09/25/18
09/25
01:35
09/25/18
01:35
General news
Asian Market Wrap: »

Asian Market Wrap:…

FDS

FactSet

$231.53

-0.05 (-0.02%)

, JBL

Jabil

$30.08

0.22 (0.74%)

20:25
09/24/18
09/24
20:25
09/24/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FDS

FactSet

$231.53

-0.05 (-0.02%)

JBL

Jabil

$30.08

0.22 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 09

    Oct

  • 13

    Nov

LOXO

Loxo Oncology

$163.07

3.91 (2.46%)

20:16
09/24/18
09/24
20:16
09/24/18
20:16
Hot Stocks
Loxo Oncology granted orphan status for solid tumors treatment »

The FDA granted Loxo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

PTLA

Portola Pharmaceuticals

$27.16

-0.39 (-1.42%)

20:15
09/24/18
09/24
20:15
09/24/18
20:15
Hot Stocks
Portola granted orphan status for cerdulatinib »

The FDA granted Portola…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Dec

TNC

Tennant

$72.75

-1.15 (-1.56%)

20:01
09/24/18
09/24
20:01
09/24/18
20:01
Hot Stocks
Tennant to Acquire Gaomei Cleaning Equipment Company, terms not stated »

Tennant Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$73.52

-1.58 (-2.10%)

19:20
09/24/18
09/24
19:20
09/24/18
19:20
Hot Stocks
Vornado now owns 100% interest in retail condo at Marriott Marquis Times Square »

Vornado Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GOOG

Alphabet

$1,173.38

7.17 (0.61%)

, GOOGL

Alphabet Class A

$1,179.78

7.56 (0.64%)

19:08
09/24/18
09/24
19:08
09/24/18
19:08
Periodicals
Google CEO to meet with top Republican lawmakers Friday, WSJ says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,173.38

7.17 (0.61%)

GOOGL

Alphabet Class A

$1,179.78

7.56 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

ASNA

Ascena Retail

$4.02

-0.21 (-4.96%)

, BAS

Basic Energy

$9.44

0.18 (1.94%)

18:56
09/24/18
09/24
18:56
09/24/18
18:56
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Ascena…

ASNA

Ascena Retail

$4.02

-0.21 (-4.96%)

BAS

Basic Energy

$9.44

0.18 (1.94%)

KEG

Key Energy

$13.46

-0.18 (-1.32%)

PSTI

Pluristem

$1.31

(0.00%)

ARNA

Arena Pharmaceuticals

$42.80

-1.05 (-2.39%)

NOVN

Novan

$2.72

0.015 (0.56%)

SNDX

Syndax

$7.23

0.46 (6.79%)

DCPH

Deciphera

$39.80

0.78 (2.00%)

BJ

BJ's Wholesale

$28.47

-0.68 (-2.33%)

PETQ

PetIQ

$41.07

-0.55 (-1.32%)

CNP

CenterPoint Energy

$27.81

-0.23 (-0.82%)

CTL

CenturyLink

$22.90

-0.04 (-0.17%)

PBR

Petrobras

$11.40

-0.105 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 01

    Oct

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 28

    Oct

  • 08

    Nov

  • 27

    Nov

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

PBR

Petrobras

$11.40

-0.105 (-0.91%)

18:54
09/24/18
09/24
18:54
09/24/18
18:54
Hot Stocks
Breaking Hot Stocks news story on Petrobras »

Petrobras reports August…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSN

VeriSign

$158.97

-0.79 (-0.49%)

18:39
09/24/18
09/24
18:39
09/24/18
18:39
Recommendations
VeriSign analyst commentary at JPMorgan »

VeriSign price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TI

Telecom Italia

$6.54

-0.1 (-1.51%)

18:35
09/24/18
09/24
18:35
09/24/18
18:35
Periodicals
Telecom Italia discussed Nextel bid at board meeting, Bloomberg says »

Telecom Italia's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSG

Inseego

$4.01

-0.08 (-1.96%)

18:31
09/24/18
09/24
18:31
09/24/18
18:31
Hot Stocks
Inseego names John Weldon to head Enterprise SaaS Solutions division »

Inseego announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$46.30

-0.48 (-1.03%)

18:31
09/24/18
09/24
18:31
09/24/18
18:31
Periodicals
PG&E says will invest $360M in electric car infrastructure, Bloomberg says »

PG&E senior manager…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 08

    Oct

  • 11

    Nov

KKR

KKR

$28.25

-0.01 (-0.04%)

18:21
09/24/18
09/24
18:21
09/24/18
18:21
Hot Stocks
KKR announces intra-quarter Q3 monetization activity »

KKR announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$267.35

0.6 (0.22%)

, EVHC

Envision Healthcare

$45.72

0.07 (0.15%)

18:17
09/24/18
09/24
18:17
09/24/18
18:17
Periodicals
UnitedHealth tells Hospitals about Envision ER contracts, Reuters says »

UnitedHealth (UNH) plans…

UNH

UnitedHealth

$267.35

0.6 (0.22%)

EVHC

Envision Healthcare

$45.72

0.07 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

AMZN

Amazon.com

$1,934.50

16.75 (0.87%)

, UBER

Uber

$0.00

(0.00%)

18:14
09/24/18
09/24
18:14
09/24/18
18:14
Periodicals
Amazon has made two approaches to buy Deliveroo, Telegraph reports »

Amazon has made two…

AMZN

Amazon.com

$1,934.50

16.75 (0.87%)

UBER

Uber

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BK

BNY Mellon

$52.36

-0.9 (-1.69%)

17:48
09/24/18
09/24
17:48
09/24/18
17:48
Hot Stocks
BNY Mellon Investment Management to close EACM Advisors »

BNY Mellon Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

EPZM

Epizyme

$10.23

-0.075 (-0.73%)

17:44
09/24/18
09/24
17:44
09/24/18
17:44
Initiation
Epizyme initiated at Leerink »

Epizyme initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 02

    Oct

NAVB

Navidea

$0.25

-0.0135 (-5.14%)

17:31
09/24/18
09/24
17:31
09/24/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Navidea »

John K. Scott, Jr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYL

Dragon Victory

$1.46

(0.00%)

17:30
09/24/18
09/24
17:30
09/24/18
17:30
Hot Stocks
Breaking Hot Stocks news story on Dragon Victory »

White Knight Ltd reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$68.18

0.89 (1.32%)

, RDS.B

Royal Dutch Shell

$70.25

0.67 (0.96%)

17:30
09/24/18
09/24
17:30
09/24/18
17:30
Periodicals
Shell CEO weighs $30B LNG export terminal in Canada, WSJ says »

Royal Dutch Shell CEO Ben…

RDS.A

Royal Dutch Shell

$68.18

0.89 (1.32%)

RDS.B

Royal Dutch Shell

$70.25

0.67 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEND

SendGrid

$35.40

-0.085 (-0.24%)

17:27
09/24/18
09/24
17:27
09/24/18
17:27
Initiation
SendGrid initiated at First Analysis »

SendGrid initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGNX

Progenics

$6.44

0.03 (0.47%)

17:25
09/24/18
09/24
17:25
09/24/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Progenics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.